Search research articles
Contact Us
Filters
Showing results (11-20 of 346) with videos related to
Page
of 35
Sort By:
Stem Cell Investigation
|
February 21, 2017
Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia
Jianbiao Zhou, Wee-Joo Chng
Biomed Research International
|
July 4, 2014
MicroRNA: important player in the pathobiology of multiple myeloma
Chonglei Bi, Wee Joo Chng
Blood Cancer Journal
|
April 30, 2021
CAR T-cell therapy in multiple myeloma: more room for improvement
Phaik Ju Teoh, Wee Joo Chng
F1000Research
|
August 11, 2017
Recent advances in acute promyelocytic leukaemia
Chin-Hin Ng, Wee-Joo Chng
European Journal of Haematology
|
July 26, 2022
Treatment horizon in multiple myeloma
Cinnie Yentia Soekojo, Wee Joo Chng
Chinese Medical Journal
|
November 2, 2011
miRNA deregulation in multiple myeloma
Chong Lei Bi, Wee Joo Chng
European Journal of Haematology
|
July 26, 2022
The evolution of immune dysfunction in multiple myeloma
Cinnie Yentia Soekojo, Wee Joo Chng
The International Journal of Biochemistry & Cell Biology
|
October 4, 2011
TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanisms
Jianbiao Zhou, Qiang Yu, Wee-Joo Chng
Cellular and Molecular Life Sciences : CMLS
|
August 2, 2018
ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia
Jianbiao Zhou, Yvonne Ng, Wee-Joo Chng
Blood
|
July 3, 2025
Deciphering the dynamics of histone acetylation and chromatin remodeling in multiple myeloma: a tale beyond the tails
Sinan Xiong, Jianbiao Zhou, Wee Joo Chng
Page
of 35
Search research articles
Search
Showing results (11-20 of 346) with videos related to
Sort By:
Page
of 35
Stem Cell Investigation
|
February 21, 2017
Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia
Jianbiao Zhou, Wee-Joo Chng
Biomed Research International
|
July 4, 2014
MicroRNA: important player in the pathobiology of multiple myeloma
Chonglei Bi, Wee Joo Chng
Blood Cancer Journal
|
April 30, 2021
CAR T-cell therapy in multiple myeloma: more room for improvement
Phaik Ju Teoh, Wee Joo Chng
F1000Research
|
August 11, 2017
Recent advances in acute promyelocytic leukaemia
Chin-Hin Ng, Wee-Joo Chng
European Journal of Haematology
|
July 26, 2022
Treatment horizon in multiple myeloma
Cinnie Yentia Soekojo, Wee Joo Chng
Chinese Medical Journal
|
November 2, 2011
miRNA deregulation in multiple myeloma
Chong Lei Bi, Wee Joo Chng
European Journal of Haematology
|
July 26, 2022
The evolution of immune dysfunction in multiple myeloma
Cinnie Yentia Soekojo, Wee Joo Chng
The International Journal of Biochemistry & Cell Biology
|
October 4, 2011
TXNIP (VDUP-1, TBP-2): a major redox regulator commonly suppressed in cancer by epigenetic mechanisms
Jianbiao Zhou, Qiang Yu, Wee-Joo Chng
Cellular and Molecular Life Sciences : CMLS
|
August 2, 2018
ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia
Jianbiao Zhou, Yvonne Ng, Wee-Joo Chng
Blood
|
July 3, 2025
Deciphering the dynamics of histone acetylation and chromatin remodeling in multiple myeloma: a tale beyond the tails
Sinan Xiong, Jianbiao Zhou, Wee Joo Chng
Page
of 35